Yohei Shirakami

16PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 15, 2026
Subcutaneous Adipose Tissue Accumulation is Associated With an Improved Prognosis in Patients With Hepatocellular Carcinoma.

Kenji Imai, Koji Takai, Mikita Oi

|Mar 21, 2026
Suppression of Indoleamine 2,3-Dioxygenase Enhances Immune Responses to the Therapeutic Vaccine for Chronic Hepatitis B.

Yohei Shirakami, Soranobu Ninomiya, Takayasu Ideta

|Feb 18, 2026
Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.

Xian-Yang Qin, Yali Xu, Hricha Mishra

|Feb 08, 2026
Clinical Characteristics of Patients With Advanced Hepatocellular Carcinoma Who Transitioned to Subsequent Therapies Following Systemic Therapy.

Kenji Imai, Koji Takai, Masashi Aiba

|Sep 27, 2025
Altered Serum Bile Acid Pattern as an Independent Factor for Covert and Overt Hepatic Encephalopathy in Patients With Cirrhosis.

Takao Miwa, Hajime Ueda, Teruo Miyazaki

|Jul 29, 2025
Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.

Kenji Imai, Koji Takai, Mikita Oi

Pageof 3

Frequent Collaborators

10 joint publications

Takao Miwa

9 joint publications

Masahito Shimizu

7 joint publications

Hiroyasu Sakai

7 joint publications

Shinji Unome